Republican governors who have banned college mask mandates are embracing
Regeneron Prescribed drugs
’ Covid-19 antibody remedy, and shares of Regeneron are mounting.
Regeneron shares (ticker: REGN) climbed 2.8% past Friday, .6% on Monday, and 3% on Tuesday. Shares were up once again early Wednesday, climbing .4%, to $650, close to its 52-7 days large. The stock is up 35% this calendar year.
Regeneron’s monoclonal antibody treatment for Covid-19, which is marketed as REGEN-COV, acquired the company $2.6 billion in profits in the next quarter of the yr as the U.S.